Tag:
Altea Therapeutics
Latest Headlines
Latest Headlines
Japanese firm buys Altea's assets, plans to launch transdermal tech
Nitto Denko has acquired all of Altea's assets, planning to use the company's transdermal technology to launch a patch on its own.
Report: Altea Therapeutics sinks after inking Lilly deal
Atlanta-based biotech Altea Therapeutics has reportedly hit the rocks. After raising more than $60 million in venture funding, and striking a development pact with Eli Lilly and Amylin
Altea inks deal for transdermal Byetta patch
Atlanta-based Altea Therapeutics has inked a $46 million deal with Eli Lilly and Amylin Pharmaceuticals to develop and commercialize a daily transdermal patch delivering sustained levels of Byetta
